LAFQX | Affiliated Fund Class R2 | Lord Abbett
Image alt tag

Error!

There was a problem contacting the server. Please try after sometime.

Sorry, we are unable to process your request.

Error!

We're sorry, but the Insights and Intelligence Tool is temporarily unavailable

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Error!

We're sorry, but the Literature Center checkout function is temporarily unavailable.

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

Reset Your Password

Financial Professionals*

Your password must be a minimum of characters.

Confirmation Message

Your LordAbbett.com password was successully updated. This page will be refreshed after 3 seconds.

OK

 

Affiliated Fund

Summary

Summary

What is the Affiliated Fund?

The Fund seeks to deliver long-term growth of capital and current income by investing primarily in dividend-paying stocks of large U.S. companies.

DIVIDEND PAYERS

True to its mandate, the Affiliated Fund is focused on companies that pay dividends.

VALUE FOCUSED

We believe a professionally-managed approach can identify companies with sustainable dividend policies whose stocks are attractively valued. 

GROWTH & INCOME

A portfolio of undervalued dividend-paying stocks may provide investors with long-term growth of capital and current income. 

Fund Basicsas of 12/31/2020

Total Net Assets
$5.75 B
Inception Date
09/28/2007
Dividend Frequency
Quarterly
Fund Expense Ratio
1.06%
Number of Holdings
72

Yield

12-Month Dividend Yield 1 as of 01/15/2021  

w/o sales charge 1.52%

30-Day Standardized Yield 2 as of 12/31/2020  

1.19%

Fund Expense Ratio :

1.06%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 09/28/2007
w/o sales charge -1.69% -1.69% 4.25% 8.91% 8.63% 4.87%
Lipper Category Avg. Equity Income Funds 4.43% 4.43% 6.47% 9.90% 9.80% -
Russell 1000® Value Index 2.80% 2.80% 6.07% 9.74% 10.50% 6.25%

Fund Expense Ratio :

1.06%

Fund Expense Ratio :

1.06%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 09/28/2007
w/o sales charge -1.69% -1.69% 4.25% 8.91% 8.63% 4.87%
Lipper Category Avg. Equity Income Funds 4.43% 4.43% 6.47% 9.90% 9.80% -
Russell 1000® Value Index 2.80% 2.80% 6.07% 9.74% 10.50% 6.25%

Fund Expense Ratio :

1.06%

RELATED CONTENT

Navigating a Changed Landscape for Dividend Stocks
May 4, 2020

We believe a focus on companies with solid balance sheets and established dividend-payment histories may be worthwhile in the current environment.

Navigating a Changed Landscape for Dividend Stocks
May 4, 2020

We believe a focus on companies with solid balance sheets and established dividend-payment histories may be worthwhile in the current environment.

Our Guide to Dividend Income, in Two Charts
January 27, 2020

Instead of focusing on current yield, investors may be better served by considering the potential growth of dividend income over time.

TEN LARGEST HOLDINGS as of 12/31/2020View Portfolio

Holding Assets
JPMorgan Chase & Co. 2.6%
NextEra Energy, Inc. 2.4%
AbbVie, Inc. 2.1%
Home Depot USA, Inc. 2.1%
Honeywell International, Inc. 2.1%
Bank of America Corp. 2.0%
Chevron Corp. 2.0%
Discover Financial Services 2.0%
Microsoft Corp. 2.0%
Procter & Gamble Co. 2.0%
% of Total Assets 21.3%

INVESTMENT TEAM

Darnell Azeez
Darnell Azeez, CFA

Managing Director, Portfolio Manager

18 Years of Industry Experience

Marc O. Pavese
Marc O. Pavese, Ph.D.

Partner & Director of Quantitative Research

20 Years of Industry Experience

Servesh Tiwari
Servesh Tiwari, CFA

Portfolio Manager

14 Years of Industry Experience

Supported By 32 Investment Professionals with 20 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

12-Month Dividend Yield 1 as of 01/15/2021  

w/o sales charge 1.52%

30-Day Standardized Yield 2 as of 12/31/2020  

  Subsidized3 Un-Subsidized4
w/o sales charge 1.19% 1.19%

Fund Expense Ratio :

1.06%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 09/28/2007
w/o sales charge -1.69% -1.69% 4.25% 8.91% 8.63% 4.87%
Lipper Category Avg. Equity Income Funds 4.43% 4.43% 6.47% 9.90% 9.80% -
Russell 1000® Value Index 2.80% 2.80% 6.07% 9.74% 10.50% 6.25%

Fund Expense Ratio :

1.06%

Fund Expense Ratio :

1.06%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 09/28/2007
w/o sales charge -1.69% -1.69% 4.25% 8.91% 8.63% 4.87%
Lipper Category Avg. Equity Income Funds 4.43% 4.43% 6.47% 9.90% 9.80% -
Russell 1000® Value Index 2.80% 2.80% 6.07% 9.74% 10.50% 6.25%

Fund Expense Ratio :

1.06%

Year Fund Returns Russell 1000® Value Index
2020 -1.69% 2.80%
2019 24.93% 26.54%
2018 -7.75% -8.27%
2017 15.63% 13.66%
2016 16.93% 17.34%
2015 -4.50% -3.83%
2014 11.63% 13.45%
2013 31.85% 32.53%
2012 15.65% 17.51%
2011 -8.15% 0.39%
2010 14.02% -
2009 19.10% -
2008 -37.30% -
2007 3.45% -
Year Q1 Q2 Q3 Q4 Yearly Returns
2021 - - - - 2.29%
2020 -28.04% 15.51% 5.22% 12.41% -1.69%
2019 10.51% 3.72% 2.40% 6.44% 24.93%
2018 -2.43% 0.41% 6.37% -11.47% -7.75%
2017 4.01% 1.91% 2.93% 5.98% 15.63%
2016 2.37% 3.06% 3.62% 6.96% 16.93%
2015 0.27% -1.32% -7.63% 4.49% -4.50%
2014 2.14% 3.91% -0.21% 5.40% 11.63%
2013 10.83% 3.79% 4.35% 9.85% 31.85%
2012 12.57% -4.75% 6.53% 1.24% 15.65%
2011 5.53% -2.76% -20.80% 13.01% -8.15%
2010 6.63% -14.42% 10.24% 13.33% 14.02%
2009 -16.43% 18.67% 16.08% 3.46% 19.10%
2008 -9.71% -6.20% -6.78% -20.58% -37.30%
2007 0.30% 5.04% 1.85% -3.60% 3.45%

NAV HISTORICAL PRICES

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioningas of 09/30/2020

  • Microsoft Corp., a software developer, is the Fund’s largest overweight position relative to its benchmark, the Russell 1000® Value Index, as of September 30, 2020. We believe Microsoft is attractively positioned for a generational shift to cloud computing thanks to a massive ecosystem, installed bases in Office, and omnipresence in large enterprises.
  • Merck & Co., Inc., a health solutions provider, is another of the Fund’s largest overweight positions relative to the benchmark. We believe that Merck is well positioned in the growing immune-oncology space with Keytruda, which has continued to gain momentum as follow on studies have shown effectiveness in multiple cancers. 
  • The Fund is also overweight relative to the benchmark in AbbVie, Inc., a biopharmaceutical company. We believe the current share price is not capturing the potential growth prospects of recent new product launches such as Skyrizi and Rinvoq. We believe the new launches have the potential to offset the impact of the Humira franchise going off patent. Further, we believe the durability of AbbVie’s aesthetics franchise is underappreciated. 

PORTFOLIO DETAILS as of 12/31/2020

Total Net Assets
$5.75 B
Number of Holdings
72
Weighted Average Market Cap.
183.8 B
P/B Ratio
3.3x
P/E Ratio
26.3x

Contributors & Detractors as of  12/31/2020

Contributors

Holding Contribution
Discover Financial Services 0.8%
JPMorgan Chase & Co. 0.7%
Lam Research Corp. 0.6%
Morgan Stanley 0.6%
Lear Corp. 0.6%

Detractors

Holding Contribution
Air Products & Chemicals, Inc. -0.2%
AstraZeneca plc -0.1%
Amgen, Inc. -0.1%
Home Depot USA, Inc. -0.1%
Lowe's Cos, Inc. -0.1%

Attribution Analysis 

Affiliated Fund Benchmark Variance
Sector Avg. Weight Base Return Avg. Weight Base Return Stock Selection Group Weight Total

Dividends & Cap Gains

Dividends & Cap Gains

Dividend Payments

For
YTD Dividends Paidas of 01/15/2021
$0
Dividend Frequency
Quarterly
Record Date Ex-Dividend Date Reinvest & Payable Date Dividend Reinvest Price
12/28/2020 12/29/2020 12/29/2020 $0.05070 $15.08
09/28/2020 09/29/2020 09/29/2020 $0.05870 $13.50
06/29/2020 06/30/2020 06/30/2020 $0.06590 $13.01
03/26/2020 03/27/2020 03/27/2020 $0.06260 $11.19

Upcoming Dividend Payment Dates

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date Reinvest & Payable Date
03/29/2021 03/30/2021 03/30/2021
06/28/2021 06/29/2021 06/29/2021
09/28/2021 09/29/2021 09/29/2021
12/28/2021 12/29/2021 12/29/2021

Capital Gains Distributions

For
Record Date Reinvest & Payable Date Long-term Short-term * Total Reinvest Price
11/20/2019 11/21/2019 $0.2639 $0.0717 $0.3356 $15.37

Upcoming Capital Gain Distribution

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date
11/22/2021 11/23/2021

Fees & Expenses

Fees & Expenses

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
n/a
Portfolio Holdings 1Q
Publish Date:11/03/2015
n/a
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
n/a
Prospectus (XBRL)
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

The Russell 1000® Value Index measures the performance of those Russell 1000 companies with lower price-to-book ratios and lower forecasted growth values.

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field